R. Volpe, The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling: A review, CUR PHARM D, 7(6), 2001, pp. 451-460
The mechanism of action of the immunosuppressive effects of antithyroid dru
gs has remained a matter of controversy, despite our earlier contention tha
t such effects in vivo were indirect; ie., it was our view that the drugs w
ere acting on the thyroid cells, reducing their thyroid hormone production
and other activities, with a consequent reduction in thyrocyte-immunocyte s
ignalling. The reduction in the activation of CD4+ cells,the increased numb
er and activation of CD8+ (and CD8+CD11b+) cells, and the reduction of solu
ble interleukin-2 receptors, thought once to be direct effects of the medic
ation, are now shown to be due to amelioration of the hyperthyroidism. Thus
the reduction in thyroid hormone production induced by the drugs is centra
l to these actions. In addition, the iodination of thyroglobulin is inhibit
ed by these agents, which may affect antigen presentation by the thyrocyte.
Furthermore, there is now evidence that the thionamides interfere with thy
rocyte expression of such molecules as Class I antigen, interleukin-l, inte
rleukin-6, prostaglandin E-2, and heat shock protein. The expression of thy
rocyte Class II antigen is probably not inhibited by these drugs, although
one group has shown that lectin-stimulated thyrocyte Class II expression is
diminished by this treatment; this group postulated that this effect might
be mediated by reduced interferon gamma production by T lymphocytes, but i
n vitro experiments do not corroborate this proposal. In any event, the act
ions as described of the effects of antithyroid drugs on the thyroid cells
(particularly normalization of thyroid function) would certainly suffice to
explain the diminution of thyroid antibodies (including thyroid stimulatin
g antibody), the reduced immunological response, and the increased remissio
n rate in Graves' disease as a consequence of antithyroid drug therapy, wit
hout the need to invoke a direct immunosuppressive effect.